Skip to main content
Labbieux
Back to VIP + MOTS-C

Research library

Explore selected publications, evidence types, key findings, and registered studies with direct links to each primary record. This curated library is not a complete archive of the thousands of studies across the wider scientific literature.

PublicationsClinical trials

48 publications

Showing records relevant to VIP + MOTS-C.

Preclinical animal

The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.

Key finding

In mice, MOTS-c activated AMPK-linked metabolic signalling and prevented age-related and high-fat-diet-induced insulin resistance and obesity.

Cell metabolism 2015

MOTS-c component foundational animal evidence. Relevant to VIP + MOTS-C

PubMed
Review

Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Key finding

This receptor review maps VIP and PACAP signalling across immune, metabolic, cardiovascular and neural systems through VPAC1, VPAC2 and PAC1 receptors.

British journal of pharmacology 2012

VIP component receptor and mechanism review. Relevant to VIP + MOTS-C

PubMed
Preclinical animal

MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.

Key finding

MOTS-c increased after exercise in people and restored physical capacity and skeletal-muscle homeostasis in aged mice.

Nature communications 2021

MOTS-c component human and animal exercise evidence. Relevant to VIP + MOTS-C

PubMed
Review

Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide.

Key finding

This review describes how VIP signalling regulates T cells and macrophages and can shift inflammatory responses toward immune-regulatory activity.

Regulatory peptides 2002

VIP component immunology review. Relevant to VIP + MOTS-C

PubMed
Observational

Increased expression of the mitochondrial derived peptide, MOTS-c, in skeletal muscle of healthy aging men is associated with myofiber composition.

Key finding

In healthy ageing men, skeletal-muscle MOTS-c expression was associated with muscle-fibre composition, linking this mitochondrial peptide to human muscle biology.

Aging 2020

MOTS-c component human observational evidence. Relevant to VIP + MOTS-C

PubMed
Review

MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.

Key finding

The study reports that different tissues co-expressed the protein with mitochondria, and plasma also contained the protein, but its level decreased with age.

Frontiers in endocrinology 2023

Component evidence for VIP + MOTS-C. Relevant to VIP + MOTS-C

PubMed
Review

The role of vasoactive intestinal peptide in pulmonary diseases.

Key finding

The study reports that vasoactive intestinal peptide (VIP) is an abundant neurotransmitter in the lungs and other organs.

Life sciences 2023

Component evidence for VIP + MOTS-C. Relevant to VIP + MOTS-C

PubMed
Review

Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system.

Key finding

The study reports that genetic ablation of this peptide and its receptors in mice also provides new insights into the contribution of VIP towards physiological signaling and the pathogenesis of related diseases.

F1000Research 2019

Component evidence for VIP + MOTS-C. Relevant to VIP + MOTS-C

PubMed
Observational

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.

Key finding

Primary pulmonary hypertension is a fatal disease causing progressive right heart failure within 3 years after diagnosis.

The Journal of clinical investigation 2003

Direct or closely related VIP evidence. Relevant to VIP + MOTS-C

PubMed
Preclinical animal

MOTS-c increases in skeletal muscle following long-term physical activity and improves acute exercise performance after a single dose.

Key finding

Skeletal muscle adapts to aerobic exercise training, in part, through fast-to-slow phenotypic shifts and an expansion of mitochondrial networks.

Physiological reports 2022

Direct or closely related MOTS-c evidence. Relevant to VIP + MOTS-C

PubMed
Preclinical animal

MOTS-c reduces myostatin and muscle atrophy signaling.

Key finding

Obesity and type 2 diabetes are metabolic diseases, often associated with sarcopenia and muscle dysfunction.

American journal of physiology. Endocrinology and metabolism 2021

Direct or closely related MOTS-c evidence. Relevant to VIP + MOTS-C

PubMed
Preclinical animal

The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity.

Key finding

MOTS-c is an exercise mimetic and improves insulin sensitivity in aged and diet-induced obese mice.

Physiological reports 2019

Direct or closely related MOTS-c evidence. Relevant to VIP + MOTS-C

PubMed
Preclinical animal

MOTS-c improves osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells via TGF-β/Smad pathway.

Key finding

MOTS-c promotes cell differentiation of BMSCs to osteoblasts via TGF-β/Smad pathway.

European review for medical and pharmacological sciences 2018

Direct or closely related MOTS-c evidence. Relevant to VIP + MOTS-C

PubMed
Preclinical animal

Mitochondria related peptide MOTS-c suppresses ovariectomy-induced bone loss via AMPK activation.

Key finding

Therapeutic targeting bone loss has been the focus of the study in osteoporosis.

Biochemical and biophysical research communications 2016

Direct or closely related MOTS-c evidence. Relevant to VIP + MOTS-C

PubMed
Preclinical animal

VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.

Key finding

Vasoactive intestinal peptide (VIP) and pituitary adenylyl cyclase-activating polypeptide (PACAP) are two structurally-related neuropeptides with widespread expression in the central and peripheral nervous systems.

Brain, behavior, and immunity 2014

Direct or closely related VIP evidence. Relevant to VIP + MOTS-C

PubMed
Preclinical animal

Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model.

Key finding

We show that vasoactive intestinal peptide (VIP) exerts trophic and proangiogenic activities in experimental prostate cancer in vivo.

Peptides 2007

Direct or closely related VIP evidence. Relevant to VIP + MOTS-C

PubMed
Published research

The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress.

Key finding

Cellular homeostasis is coordinated through communication between mitochondria and the nucleus, organelles that each possess their own genomes.

Cell metabolism 2018

Direct or closely related MOTS-c evidence. Relevant to VIP + MOTS-C

PubMed
Observational

Plasma mitochondrial derived peptides MOTS-c and SHLP2 positively associate with android and liver fat in people without diabetes.

Key finding

Mitochondrial-derived peptides (MDPs) are encoded by the mitochondrial genome and hypothesised to form part of a retrograde signalling network that modulates adaptive responses to metabolic stress.

Biochimica et biophysica acta. General subjects 2021

Direct or closely related MOTS-c evidence. Relevant to VIP + MOTS-C

PubMed
Observational

Inhalation of vasoactive intestinal peptide in pulmonary hypertension.

Key finding

Pulmonary hypertension (PH) leads to an increased right ventricular workload, cardiac failure and death.

The European respiratory journal 2008

Direct or closely related VIP evidence. Relevant to VIP + MOTS-C

PubMed
Observational

Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis.

Key finding

The identification of regulatory T (Treg) cells as important regulators of self-tolerance has opened up new therapeutic avenues for the treatment of several human diseases associated with Treg dysfunction, including autoimmune diseases and transplantation.

Trends in molecular medicine 2007

Direct or closely related VIP evidence. Relevant to VIP + MOTS-C

PubMed

This library supports source-led professional evaluation. Product-specific clinical and regulatory guidance provides the framework for interpreting the records in context.

Browse all products